MarketPeel
JB

Jeffrey Bluestone

GILD
DIRECTOR · GILEAD SCIENCES, INC. · CIK 0001771814
FILING MIX · LIFETIME59%/41%
BUYS
26
SELLS
18
TOTAL VALUE
$5.89M
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
10,092
AVG SELL PX
$117.11
TRADE KIND
SHOWING 44 / 44
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeffrey Bluestone, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+1.93%+1.04%+0.90%-1.65%
14d4+25.00%+3.25%+0.96%+2.30%-0.19%
30d4+25.00%+7.88%+1.33%+6.55%+3.43%
60d4+0.00%+6.66%+1.07%+5.59%+5.29%
90d4+0.00%+12.68%+2.83%+9.84%+9.12%
180d4+0.00%+10.00%+5.94%+5.31%-1.53%
1y4(2 pending)+0.00%+27.70%+16.89%+10.81%+10.81%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GILD · 10,092 shares · as of Aug 20, 2026
03,9637,92611,88815,851202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 26 buys / 18 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GILD
GILEAD SCIENCES, INC.
PURCHASE
26$67.45$1.8K10,092Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
335$61.35$20.6K10,401Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
26$146.36$3.8K10,066Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
1,816$144.92$263.2K10,066Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
1,658$145.73$241.6K10,066Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
1,165$67.45$78.6K11,231Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
1,658$67.45$111.8K11,724Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
1,165$143.75$167.5K10,066Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
4,6650Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
33511,395Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
1,816$67.45$122.5K11,882Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
335$146.26$49.0K10,066Aug 20, 2026Aug 21, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
1,14610,066Apr 30, 2026May 4, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
4,8844,884Apr 30, 2026May 4, 2026View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
5,000$67.45$337.3K13,920Jan 20, 2026Jan 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
5,0004,665Jan 20, 2026Jan 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
5,000$123.50$617.5K8,920Jan 20, 2026Jan 21, 2026View →
GILD
GILEAD SCIENCES, INC.
SALE
5,000$125.08$625.4K8,920Nov 28, 2025Dec 1, 2025View →
GILD
GILEAD SCIENCES, INC.
SALE
5,0007,648Nov 28, 2025Dec 1, 2025View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
5,000$64.92$324.6K13,920Nov 28, 2025Dec 1, 2025View →
GILD
GILEAD SCIENCES, INC.
SALE10b5-1
10b5-1 plan
5,000$109.74$548.7K8,920Jul 14, 2025Jul 15, 2025View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
5,000$67.45$337.3K13,920Jul 14, 2025Jul 15, 2025View →
GILD
GILEAD SCIENCES, INC.
SALE
5,0009,665Jul 14, 2025Jul 15, 2025View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
1,5165,713May 7, 2025May 8, 2025View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
6,8096,809May 7, 2025May 8, 2025View →
GILD
GILEAD SCIENCES, INC.
SALE
4,12111,730Nov 26, 2024Nov 27, 2024View →
GILD
GILEAD SCIENCES, INC.
SALE
6,788$91.39$620.4K8,920Nov 26, 2024Nov 27, 2024View →
GILD
GILEAD SCIENCES, INC.
SALE
5,8790Nov 26, 2024Nov 27, 2024View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
4,121$61.35$252.8K15,708Nov 26, 2024Nov 27, 2024View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
5,879$61.17$359.6K11,587Nov 26, 2024Nov 27, 2024View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
12,64812,648May 8, 2024May 9, 2024View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
2,3104,197May 8, 2024May 9, 2024View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
10,173$79.45$808.2K10,173May 3, 2023May 4, 2023View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
1,8871,887May 3, 2023May 4, 2023View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
2,4445,708May 5, 2022May 6, 2022View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
15,85115,851May 5, 2022May 6, 2022View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
2,2233,264May 3, 2022May 3, 2022View →
GILD
GILEAD SCIENCES, INC.
SALE
2,2230May 3, 2022May 3, 2022View →
GILD
GILEAD SCIENCES, INC.
PURCHASE
1,0411,041Dec 8, 2021Dec 9, 2021View →
GILD
GILEAD SCIENCES, INC.
SALE
1,0412,223Dec 8, 2021Dec 9, 2021View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
14,66514,665May 12, 2021May 14, 2021View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
2,2233,264May 12, 2021May 14, 2021View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
1,0411,041Dec 8, 2020Dec 10, 2020View →
GILD
GILEAD SCIENCES, INC.
PURCHASEGRANT
Stock grant
5,8795,879Dec 8, 2020Dec 10, 2020View →
Other insiders · GILD
Loading peer insiders…
About this filer
CIK 0001771814
ROLE
Director
PRIMARY
GILD
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001771814DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback